Cargando…
Managing Multi-center Flow Cytometry Data for Immune Monitoring
With the recent results of promising cancer vaccines and immunotherapy1–5, immune monitoring has become increasingly relevant for measuring treatment-induced effects on T cells, and an essential tool for shedding light on the mechanisms responsible for a successful treatment. Flow cytometry is the c...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463798/ https://www.ncbi.nlm.nih.gov/pubmed/26085786 http://dx.doi.org/10.4137/CIN.S16346 |
_version_ | 1782375839320506368 |
---|---|
author | White, Scott Laske, Karoline Welters, Marij JP Bidmon, Nicole van der Burg, Sjoerd H Britten, Cedrik M Enzor, Jennifer Staats, Janet Weinhold, Kent J Gouttefangeas, Cécile Chan, Cliburn |
author_facet | White, Scott Laske, Karoline Welters, Marij JP Bidmon, Nicole van der Burg, Sjoerd H Britten, Cedrik M Enzor, Jennifer Staats, Janet Weinhold, Kent J Gouttefangeas, Cécile Chan, Cliburn |
author_sort | White, Scott |
collection | PubMed |
description | With the recent results of promising cancer vaccines and immunotherapy1–5, immune monitoring has become increasingly relevant for measuring treatment-induced effects on T cells, and an essential tool for shedding light on the mechanisms responsible for a successful treatment. Flow cytometry is the canonical multi-parameter assay for the fine characterization of single cells in solution, and is ubiquitously used in pre-clinical tumor immunology and in cancer immunotherapy trials. Current state-of-the-art polychromatic flow cytometry involves multi-step, multi-reagent assays followed by sample acquisition on sophisticated instruments capable of capturing up to 20 parameters per cell at a rate of tens of thousands of cells per second. Given the complexity of flow cytometry assays, reproducibility is a major concern, especially for multi-center studies. A promising approach for improving reproducibility is the use of automated analysis borrowing from statistics, machine learning and information visualization21–23, as these methods directly address the subjectivity, operator-dependence, labor-intensive and low fidelity of manual analysis. However, it is quite time-consuming to investigate and test new automated analysis techniques on large data sets without some centralized information management system. For large-scale automated analysis to be practical, the presence of consistent and high-quality data linked to the raw FCS files is indispensable. In particular, the use of machine-readable standard vocabularies to characterize channel metadata is essential when constructing analytic pipelines to avoid errors in processing, analysis and interpretation of results. For automation, this high-quality metadata needs to be programmatically accessible, implying the need for a consistent Application Programming Interface (API). In this manuscript, we propose that upfront time spent normalizing flow cytometry data to conform to carefully designed data models enables automated analysis, potentially saving time in the long run. The ReFlow informatics framework was developed to address these data management challenges. |
format | Online Article Text |
id | pubmed-4463798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-44637982015-06-17 Managing Multi-center Flow Cytometry Data for Immune Monitoring White, Scott Laske, Karoline Welters, Marij JP Bidmon, Nicole van der Burg, Sjoerd H Britten, Cedrik M Enzor, Jennifer Staats, Janet Weinhold, Kent J Gouttefangeas, Cécile Chan, Cliburn Cancer Inform Original Research With the recent results of promising cancer vaccines and immunotherapy1–5, immune monitoring has become increasingly relevant for measuring treatment-induced effects on T cells, and an essential tool for shedding light on the mechanisms responsible for a successful treatment. Flow cytometry is the canonical multi-parameter assay for the fine characterization of single cells in solution, and is ubiquitously used in pre-clinical tumor immunology and in cancer immunotherapy trials. Current state-of-the-art polychromatic flow cytometry involves multi-step, multi-reagent assays followed by sample acquisition on sophisticated instruments capable of capturing up to 20 parameters per cell at a rate of tens of thousands of cells per second. Given the complexity of flow cytometry assays, reproducibility is a major concern, especially for multi-center studies. A promising approach for improving reproducibility is the use of automated analysis borrowing from statistics, machine learning and information visualization21–23, as these methods directly address the subjectivity, operator-dependence, labor-intensive and low fidelity of manual analysis. However, it is quite time-consuming to investigate and test new automated analysis techniques on large data sets without some centralized information management system. For large-scale automated analysis to be practical, the presence of consistent and high-quality data linked to the raw FCS files is indispensable. In particular, the use of machine-readable standard vocabularies to characterize channel metadata is essential when constructing analytic pipelines to avoid errors in processing, analysis and interpretation of results. For automation, this high-quality metadata needs to be programmatically accessible, implying the need for a consistent Application Programming Interface (API). In this manuscript, we propose that upfront time spent normalizing flow cytometry data to conform to carefully designed data models enables automated analysis, potentially saving time in the long run. The ReFlow informatics framework was developed to address these data management challenges. Libertas Academica 2015-06-10 /pmc/articles/PMC4463798/ /pubmed/26085786 http://dx.doi.org/10.4137/CIN.S16346 Text en © 2014 the author(s), publisher and licensee Libertas Academica Limited This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License. |
spellingShingle | Original Research White, Scott Laske, Karoline Welters, Marij JP Bidmon, Nicole van der Burg, Sjoerd H Britten, Cedrik M Enzor, Jennifer Staats, Janet Weinhold, Kent J Gouttefangeas, Cécile Chan, Cliburn Managing Multi-center Flow Cytometry Data for Immune Monitoring |
title | Managing Multi-center Flow Cytometry Data for Immune Monitoring |
title_full | Managing Multi-center Flow Cytometry Data for Immune Monitoring |
title_fullStr | Managing Multi-center Flow Cytometry Data for Immune Monitoring |
title_full_unstemmed | Managing Multi-center Flow Cytometry Data for Immune Monitoring |
title_short | Managing Multi-center Flow Cytometry Data for Immune Monitoring |
title_sort | managing multi-center flow cytometry data for immune monitoring |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463798/ https://www.ncbi.nlm.nih.gov/pubmed/26085786 http://dx.doi.org/10.4137/CIN.S16346 |
work_keys_str_mv | AT whitescott managingmulticenterflowcytometrydataforimmunemonitoring AT laskekaroline managingmulticenterflowcytometrydataforimmunemonitoring AT weltersmarijjp managingmulticenterflowcytometrydataforimmunemonitoring AT bidmonnicole managingmulticenterflowcytometrydataforimmunemonitoring AT vanderburgsjoerdh managingmulticenterflowcytometrydataforimmunemonitoring AT brittencedrikm managingmulticenterflowcytometrydataforimmunemonitoring AT enzorjennifer managingmulticenterflowcytometrydataforimmunemonitoring AT staatsjanet managingmulticenterflowcytometrydataforimmunemonitoring AT weinholdkentj managingmulticenterflowcytometrydataforimmunemonitoring AT gouttefangeascecile managingmulticenterflowcytometrydataforimmunemonitoring AT chancliburn managingmulticenterflowcytometrydataforimmunemonitoring |